The Food and Drug Administration recently revealed that the popular heartburn medication known as Zantac® contains low levels of a cancer-causing contaminant known as NDMA. NDMA was previously identified in a blood pressure drug, leading to recalls.
Sanofi and other generic companies make Zantac, sold prescription and non-prescription versions. On April 1, 2020 the U.S. Food and Drug Administration announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This was due to significant concerns about the risk of cancers of the liver, stomach, bladder, kidney, and other organs, especially for those who regularly used the drug for at least 60 days.
The FDA warning has raised serious questions about the heartburn drug's safety, especially for those diagnosed with cancer after having used Zantac or one of its generic versions.
If you or someone you loved took Zantac regularly for at least two months or diagnosed with cancer six months or more after the last time you took the drug for a year, you may be eligible to file a Zantac lawsuit.
If you took Zantac or one of its generics regularly and were diagnosed afterward with cancer, you may be eligible to file a lawsuit against the drug's manufacturer and receive compensation for your medical expenses, lost wages, pain and suffering and more. We have helped thousands of people get the justice they deserve, and we can help you too.
Contact us and we'll provide you with a no-cost evaluation of the compensation you could receive. Our review is completely free, and if we represent you and you are compensated you'll pay no out-of-pocket costs at all.
Our experienced team will evaluate your claim and help you maximize the amount of money you receive. Time is limited. Act now to receive compensation.